EUVIMEDEUVIMED entdecken
Crossref

NDRG1 expression in cancers confers dependence on DNA damage repair and sensitivity to quinacrine

Garik V Mkrtchyan iD, Alexander Veviorskiy iD, Zarah G Meisen iD, Michael A Petr iD, Tobias Clausen Mercurio iD, Daniela Bakula iD, Peter Sykora iD, Li-Wei Kuo iD, Dean S Rosenthal iD, Cynthia M Simbulan-Rosenthal, Peiran Zhang iD, Qiuqiong Tang und 5 weitere

Science Signaling · 21.07.2026 · 19 (947)

DOI: 10.1126/scisignal.adv4272 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Signaling, erschienen am 21.07.2026. Verfasst von Garik V Mkrtchyan und 16 weiteren Autor:innen. Beteiligte Einrichtung: Center for Healthy Aging, Department of Cellular and Molecular Medicine, University of Copenhagen, Copenhagen, Denmark. Hauptthemen laut MEDLINE: DNA Repair, Cell Cycle Proteins, DNA Damage, Quinacrine. Die Arbeit nennt 75 Literaturangaben. Gefördert von: Lundbeck Foundation, Danish Cancer Society, Novo Nordisk Foundation Challenge Programme.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer cells exploit DNA repair to overcome damage and errors induced by rapid proliferation and repressed checkpoints. Thus, the loss of one DNA repair protein can make tumors more susceptible to inhibition of other repair pathways. Here, using in silico methodologies and high-content genetic and cell survival screens, we found that the antimalarial drug quinacrine impaired the DNA damage response (DDR) in multiple cancer cell lines. Quinacrine disrupted the interaction of the stress-response protein NDRG1 with the major segregase VCP, which in turn promoted the degradation of the E3 ubiquitin ligase RNF8 and other proteins that mediate the recruitment of the critical DDR protein 53BP1 to sites of DNA damage. This impaired recruitment of 53BP1 caused increases in the DNA damage marker γH2AX. High NDRG1 expression in tumors correlated with poor survival in patients, and high expression in various cancer cell lines correlated with quinacrine sensitivity. Colorectal carcinoma cells were particularly vulnerable to pharmacological or genetic inhibition of NDRG1, and high NDRG1 expression and mutations in MLH1 and PARP3 resulted in synthetic lethality. Our findings identify combination genetic markers that might be therapeutically exploited in colon cancer, as well as provide a platform for such discovery in distinct cancer types.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA RepairCell Cycle ProteinsDNA DamageQuinacrineIntracellular Signaling Peptides and ProteinsGene Expression Regulation, NeoplasticHumansN-myc Downstream-Regulated Gene 1 ProteinCell Line, TumorMutL Protein Homolog 1Tumor Suppressor p53-Binding Protein 1

Substanzen

Cell Cycle ProteinsQuinacrineIntracellular Signaling Peptides and ProteinsN-myc Downstream-Regulated Gene 1 ProteinMLH1 protein, humanMutL Protein Homolog 1Tumor Suppressor p53-Binding Protein 1TP53BP1 protein, human

Autor:innen und Institutionen

  • Center for Healthy Aging, Department of Cellular and Molecular Medicine, University of Copenhagen, Copenhagen, Denmark.
  • Insilico Medicine AI Limited, Abu Dhabi, UAE.
  • Amelia Technologies LLC, Washington, DC 20001, USA.
  • Department of Biochemistry and Molecular and Cellular Biology, Georgetown University School of Medicine, Washington, DC 20057, USA.
  • Insilico Medicine Suzhou Ltd., Suzhou, China.
  • CANDLE Synchrotron Research Institute, 31 Acharyan, 0040 Yerevan, Armenia.

ORCID-Profile: Garik V Mkrtchyan, Alexander Veviorskiy, Zarah G Meisen, Michael A Petr, Tobias Clausen Mercurio, Daniela Bakula, Peter Sykora, Li-Wei Kuo, Dean S Rosenthal, Peiran Zhang, Alex Zhavoronkov

Förderung

  • Lundbeck Foundation
  • Danish Cancer Society
  • Novo Nordisk Foundation Challenge Programme
  • Nordea Foundation
  • Danish Ministry of Higher Education and Science
  • Insilico Medicine

Zitieren

APA

Mkrtchyan, G. V., Veviorskiy, A., Meisen, Z. G., Petr, M. A., Mercurio, T. C., Bakula, D., Sykora, P., Kuo, L. W., Rosenthal, D. S., Simbulan-Rosenthal, C. M., Zhang, P., Tang, Q., Osipov, A. N., Ozerov, I. V., Aliper, A., Zhavoronkov, A., & Scheibye-Knudsen, M. (2026). NDRG1 expression in cancers confers dependence on DNA damage repair and sensitivity to quinacrine. Science Signaling, 19(947). https://doi.org/10.1126/scisignal.adv4272

Vancouver

Mkrtchyan GV, Veviorskiy A, Meisen ZG, Petr MA, Mercurio TC, Bakula D, et al. NDRG1 expression in cancers confers dependence on DNA damage repair and sensitivity to quinacrine. Science Signaling. 2026;19(947). doi:10.1126/scisignal.adv4272

BibTeX
@article{Mkrtchyan2026,
  author = {Mkrtchyan, Garik V and Veviorskiy, Alexander and Meisen, Zarah G and Petr, Michael A and Mercurio, Tobias Clausen and Bakula, Daniela and Sykora, Peter and Kuo, Li-Wei and Rosenthal, Dean S and Simbulan-Rosenthal, Cynthia M and Zhang, Peiran and Tang, Qiuqiong and Osipov, Andreyan N and Ozerov, Ivan V and Aliper, Alex and Zhavoronkov, Alex and Scheibye-Knudsen, Morten},
  title = {NDRG1 expression in cancers confers dependence on DNA damage repair and sensitivity to quinacrine},
  journal = {Science Signaling},
  year = {2026},
  volume = {19},
  number = {947},
  doi = {10.1126/scisignal.adv4272}
}
Kostenlos starten →